Livingbridge Invests in Veramed

November 5, 2021

Livingbridge has made a minority growth investment in Veramed, a London-headquartered biometrics Contract Research Organization (CRO) that provides biostatistics, programming and study reporting services to pharmaceutical and biotech clients. The founders, Matthew and Emma Jones, will retain a significant shareholding and management will remain in place; Livingbridge's Enterprise 3 fund will support Veramed's geographic expansion and capability broadening.

Buyers
Livingbridge
Targets
Veramed
Sellers
Founders Matthew Jones and Emma Jones
Location
England, United Kingdom
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.